Healthy volunteers platelet exosome study
Part of Blood & lymphatic clinical trials.
This study looks at tiny particles released by platelets in healthy people. It aims to understand what these particles normally look like.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy with no known medical conditions.
- You cannot have any diseases affecting your digestive, liver, kidney, blood, immune, metabolic, or breathing systems.
- You must not have had cancer, heart disease, or permanent organ damage.
- You must not have had a major injury or surgery in the last 6 months.
- You must not have taken any medication in the last 15 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at healthy adults who donate platelets to understand how platelets change over time. You must fast before blood draws and avoid certain medicines like aspirin or ibuprofen for a week before each visit.
This study looks at how platelets work and checks blood markers using donations from healthy volunteers. It may help researchers design future platelet-related treatments and better tests.
This study looks at how well platelets are collected and spread out when using a tube with EDTA. It is important for people who do not have blood clotting problems.
This study looks at how fats (lipids) in your blood affect blood cells called platelets, which help with clotting. It includes both healthy people and those with high cholesterol or other fat issues.
This study looks for markers in the blood that are linked to fatigue in people with low platelets. It compares patients who have low platelets from immune or inherited causes to healthy volunteers, to understand why some feel very tired.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
Hear when a new Platelet Thrombus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.